These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
271 related articles for article (PubMed ID: 11929812)
1. Metabolic markers of breast cancer: enhanced choline metabolism and reduced choline-ether-phospholipid synthesis. Katz-Brull R; Seger D; Rivenson-Segal D; Rushkin E; Degani H Cancer Res; 2002 Apr; 62(7):1966-70. PubMed ID: 11929812 [TBL] [Abstract][Full Text] [Related]
2. Molecular causes of the aberrant choline phospholipid metabolism in breast cancer. Glunde K; Jie C; Bhujwalla ZM Cancer Res; 2004 Jun; 64(12):4270-6. PubMed ID: 15205341 [TBL] [Abstract][Full Text] [Related]
3. Malignant transformation alters membrane choline phospholipid metabolism of human mammary epithelial cells. Aboagye EO; Bhujwalla ZM Cancer Res; 1999 Jan; 59(1):80-4. PubMed ID: 9892190 [TBL] [Abstract][Full Text] [Related]
4. Variations in energy and phospholipid metabolism in normal and cancer human mammary epithelial cells. Ting YL; Sherr D; Degani H Anticancer Res; 1996; 16(3B):1381-8. PubMed ID: 8694505 [TBL] [Abstract][Full Text] [Related]
5. Noninvasive magnetic resonance spectroscopic pharmacodynamic markers of the choline kinase inhibitor MN58b in human carcinoma models. Al-Saffar NM; Troy H; RamÃrez de Molina A; Jackson LE; Madhu B; Griffiths JR; Leach MO; Workman P; Lacal JC; Judson IR; Chung YL Cancer Res; 2006 Jan; 66(1):427-34. PubMed ID: 16397258 [TBL] [Abstract][Full Text] [Related]
7. Kinetics of choline transport and phosphorylation in human breast cancer cells; NMR application of the zero trans method. Katz-Brull R; Degani H Anticancer Res; 1996; 16(3B):1375-80. PubMed ID: 8694504 [TBL] [Abstract][Full Text] [Related]
8. Pyruvate utilization, phosphocholine and adenosine triphosphate (ATP) are markers of human breast tumor progression: a 31P- and 13C-nuclear magnetic resonance (NMR) spectroscopy study. Singer S; Souza K; Thilly WG Cancer Res; 1995 Nov; 55(22):5140-5. PubMed ID: 7585561 [TBL] [Abstract][Full Text] [Related]
9. Levels of phospholipid metabolites in breast cancer cells treated with antimitotic drugs: a 31P-magnetic resonance spectroscopy study. Sterin M; Cohen JS; Mardor Y; Berman E; Ringel I Cancer Res; 2001 Oct; 61(20):7536-43. PubMed ID: 11606391 [TBL] [Abstract][Full Text] [Related]
10. Metabolic and morphological differences between rapidly proliferating cancerous and normal breast epithelial cells. Meadows AL; Kong B; Berdichevsky M; Roy S; Rosiva R; Blanch HW; Clark DS Biotechnol Prog; 2008; 24(2):334-41. PubMed ID: 18307352 [TBL] [Abstract][Full Text] [Related]
11. Phosphocholine as a biomarker of breast cancer: molecular and biochemical studies. Eliyahu G; Kreizman T; Degani H Int J Cancer; 2007 Apr; 120(8):1721-30. PubMed ID: 17236204 [TBL] [Abstract][Full Text] [Related]
12. Choline metabolism in breast cancer; 2H-, 13C- and 31P-NMR studies of cells and tumors. Katz-Brull R; Margalit R; Bendel P; Degani H MAGMA; 1998 Aug; 6(1):44-52. PubMed ID: 9794289 [TBL] [Abstract][Full Text] [Related]
13. Nuclear magnetic resonance analysis of tumor necrosis factor-induced alterations of phospholipid metabolites and pH in Friend leukemia cell tumors and fibrosarcomas in mice. Podo F; Carpinelli G; Di Vito M; Giannini M; Proietti E; Fiers W; Gresser I; Belardelli F Cancer Res; 1987 Dec; 47(24 Pt 1):6481-9. PubMed ID: 3677088 [TBL] [Abstract][Full Text] [Related]
14. RNA interference-mediated choline kinase suppression in breast cancer cells induces differentiation and reduces proliferation. Glunde K; Raman V; Mori N; Bhujwalla ZM Cancer Res; 2005 Dec; 65(23):11034-43. PubMed ID: 16322253 [TBL] [Abstract][Full Text] [Related]
15. Accumulation of fatty alcohol in MCF-7 breast cancer cells. Welsh CJ; Robinson M; Warne TR; Pierce JH; Yeh GC; Phang JM Arch Biochem Biophys; 1994 Nov; 315(1):41-7. PubMed ID: 7979403 [TBL] [Abstract][Full Text] [Related]
16. Regulation of the cytidine phospholipid pathways in human cancer cells and effects of 1-beta-D-arabinofuranosylcytosine: a noninvasive 31P nuclear magnetic resonance study. Daly PF; Zugmaier G; Sandler D; Carpen M; Myers CE; Cohen JS Cancer Res; 1990 Feb; 50(3):552-7. PubMed ID: 2153442 [TBL] [Abstract][Full Text] [Related]
17. Melanoma tumors acquire a new phospholipid metabolism phenotype under cystemustine as revealed by high-resolution magic angle spinning proton nuclear magnetic resonance spectroscopy of intact tumor samples. Morvan D; Demidem A; Papon J; De Latour M; Madelmont JC Cancer Res; 2002 Mar; 62(6):1890-7. PubMed ID: 11912170 [TBL] [Abstract][Full Text] [Related]